XenoGesis and Juniper Pharma Services have extended their partnership in early drug development services by adding GastroPlus, PBPK modelling and simulation software. Read more


A significant investment has been made by drug metabolism and pharmacokinetics (DMPK) business XenoGesis in a brand new LC-MS/MS machine, bringing the company's total number of mass spec machines at its BioCity base to three. Read more


The collaboration that will support pharmaceutical and biotech drug developers during the pre-clinical and formulation development stage. Read more